ConductScience.org, home

Library / Genes

IL13: interleukin 13

1 protein, 104 patents, 7 drugs, 93 trials, 16,343 NIH grants and 48,453 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolIL13HGNC
Nameinterleukin 13HGNC
NCBI Gene ID3596NCBI Gene
HGNC IDHGNC:5973HGNC
EnsemblENSG00000169194NCBI Gene
AliasesALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P35225Interleukin-1314613Ensembl, GeneID, HGNCUniProt

Patents 104

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
WO 2026190494 A12026-09-1785P35225Espacenet
WO 2026170046 A12026-08-13161P35225Espacenet
JP 2026505362 A2026-02-1333P35225Espacenet
EP 4661884 A22025-12-1733P35225Espacenet
EP 4640849 A22025-10-29563P35225Espacenet
EP 4641201 A22025-10-293854P35225Espacenet
EP 4641202 A22025-10-294800P35225Espacenet
JP 2025147176 A2025-10-066878P35225Espacenet
WO 2025177214 A12025-08-2837P35225Espacenet
JP 2025519096 A2025-06-24563P35225Espacenet

Drugs 7

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ANRUKINZUMABCHEMBL1742985Interleukin-13 inhibitorINHIBITORChEMBL
CENDAKIMABCHEMBL4297864Interleukin-13 inhibitorINHIBITORChEMBL
CNTO-5825CHEMBL2109464Interleukin-13 inhibitorINHIBITORChEMBL
LEBRIKIZUMABCHEMBL1743035Interleukin-13 inhibitorINHIBITORChEMBL
QAX-576CHEMBL2109465Interleukin-13 inhibitorINHIBITORChEMBL
ROMILKIMABCHEMBL4298097Interleukin-13 inhibitorINHIBITORChEMBL
TRALOKINUMABCHEMBL1743081Interleukin-13 inhibitorINHIBITORChEMBL

Trials 93

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource
NCT07444801TRALOKINUMABClinicalTrials.gov
NCT07006792LEBRIKIZUMABPHASE4ClinicalTrials.gov
NCT06906497LEBRIKIZUMABPHASE4ClinicalTrials.gov
NCT06882148TRALOKINUMABClinicalTrials.gov
NCT06773455TRALOKINUMABPHASE4ClinicalTrials.gov
NCT06526182LEBRIKIZUMABPHASE3ClinicalTrials.gov
NCT06339008LEBRIKIZUMABPHASE3ClinicalTrials.gov
NCT06338995LEBRIKIZUMABPHASE3ClinicalTrials.gov
NCT06311682TRALOKINUMABPHASE3ClinicalTrials.gov
NCT06280716LEBRIKIZUMABPHASE3ClinicalTrials.gov

NIH grants 16343

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
U19AI070235Epithelial Genes in Allergic Inflammation962,025NIH's project files
P30DK078392Digestive Health Center (DHC): Bench to Bedside Research in Pediatric Digestive Disease932,025NIH's project files
P30CA008748Cancer Center Support Grant762,025NIH's project files
P30CA016672Cancer Center Support Grant752,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award632,025NIH's project files
U19AI095227Viral and Host Determinants of Infant and Childhood Allergy and Asthma562,025NIH's project files
U19AI077439Immune-driven Airway Epithelial Dysfunction in Muco-obstructive Asthma452,025NIH's project files
U19AI070535Airway Inflammation and Airway Remodeling in Severe Asthma442,025NIH's project files
R01AI124355Genetic and Immunological Dissection of Eosinophilic Esophagitis372,025NIH's project files
ZIAAI001065India International Center for Excellence in Research362,025NIH's project files

Papers 48453

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42827467PubTator, text miningPubMed
42826153PubTator, text miningPubMed
42824269PubTator, text miningPubMed
42823320PubTator, text miningPubMed
42823180PubTator, text miningPubMed
42818841PubTator, text miningPubMed
42818167PubTator, text miningPubMed
42816545PubTator, text miningPubMed
42813198PubTator, text miningPubMed
42813189PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license